RBR-2wsdt6进行中（未招募）未知
Evaluation of implementation of 300mg isoniazide for the treatment of latent Infection of tuberculosis in Brazil
niversidade Federal do Espirito Santo0 个研究点开始时间: 2018年9月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 80Y（—）
入选标准
- •All individuals over 18 years of age with indication for ILTB treatment
排除标准
- •Individuals whose case index is a multiresistant and extremely resistant case, as well as those individuals who were transferred from the original center after two or more weeks of treatment initiation beyond the individuals in the prison system will be excluded.In addition, people over 80 years old will be excluded.
研究者
相似试验
尚未招募
不适用
Evaluation of Isoniazid 300 mg Drug for the Treatment of Latent Tuberculosis Infection in Brazilatent TuberculosisC01.252.410.040.552.846.122RBR-8wjq29niversidade Federal do Espirito Santo
已完成
不适用
STUDY OF EFFECTIVENESS AND TOLERABILITY OF ISONIAZIDE / RIFAPENTIN ONCE A WEEK FOR THREE MONTHS VERSUS ISONIAZIDE DAILY FOR NINE MONTHS FOR THE TREATMENT OF A LATENT INFECTION WITH TUBERCULOSIS-B24 Unspecified human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseB24PER-016-09Institutos Nacionales de Salud (NIH, siglas en ingles) de los Estados Unidos de America,32
进行中（未招募）
不适用
Evaluation of a Moxifloxacin-Based, Isoniazid-Sparing Regimen for Tuberculosis Treatment TBTC/UITB Study 28 - Moxifloxacin for IsoniazidEUCTR2005-003312-29-ESTB Investigation Unit of Barcelona410
已完成
不适用
Study for the efficacy and appropriate dosing of insulin degludec, an ultra long-acting insulin, in patients with type 1 diabetesType 1 diabetes mellitusJPRN-UMIN000010634Kitano Hospital, The Tazuke Kofukai Medical Research Institute30
尚未招募
2 期
Evaluating effectiveness of therapy with topical isoniazid in melasmamelasma.Other melanin hyperpigmentationL81.4IRCT20211125053175N1Kerman University of Medical Sciences20